These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2803702)

  • 21. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the dopamine D-1 antagonist SCH 23390 on water intake, water-rewarded operant responding and apomorphine-induced decrease of water intake in rats.
    Ljungberg T
    Pharmacol Biochem Behav; 1989 Jul; 33(3):709-12. PubMed ID: 2685829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of age on behavioral responses to dopamine agonists in the rat.
    Ushijima I; Mizuki Y; Soeda K; Kishimoto O; Hara T; Yamada M
    Eur J Pharmacol; 1987 Jun; 138(1):101-6. PubMed ID: 2887433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
    Protais P; Dubuc I; Costentin J
    Eur J Pharmacol; 1983 Oct; 94(3-4):271-80. PubMed ID: 6140175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of D-1 and D-2 receptors in apomorphine-induced pecking in chicks.
    Zarrindast MR; Amin R
    Psychopharmacology (Berl); 1992; 106(1):67-70. PubMed ID: 1346722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat.
    Przegaliński E; Jaworska L; Konarska R; Gołembiowska K
    Neuropeptides; 1991 Jul; 19(3):189-95. PubMed ID: 1680223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the effects of amphetamine and low doses of apomorphine on operant force production, inter-response times and response duration in rat.
    Liu X; Strecker RE; Brener J
    Psychopharmacology (Berl); 1999 Aug; 145(4):351-9. PubMed ID: 10460311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76.
    Dourish CT; Herbert EN; Iversen SD
    Neuropharmacology; 1989 Dec; 28(12):1423-5. PubMed ID: 2615920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
    Fayle P; Jackson DM; Jenkins OF; Lafferty PA
    Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
    Brog JS; Beinfeld MC
    J Pharmacol Exp Ther; 1992 Jan; 260(1):343-8. PubMed ID: 1346163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen.
    Mereu G; Muntoni F; Calabresi P; Romani F; Boi V; Gessa GL
    Neurosci Lett; 1986 Apr; 65(2):161-6. PubMed ID: 3714103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of fencamfamine on single unit activity of mesencephalic dopaminergic neurons in rats.
    Matthews RT
    J Neural Transm; 1988; 71(1):45-55. PubMed ID: 3343595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple method for the study of yawning in man induced by the dopamine receptor agonist, apomorphine.
    Lal S; Grassino A; Thavundayil JX; Dubrovsky B
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):223-8. PubMed ID: 3628829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):285-98. PubMed ID: 3995296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
    Nissbrandt H; Pileblad E; Carlsson A
    J Pharm Pharmacol; 1985 Dec; 37(12):884-9. PubMed ID: 2868096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
    Urba-Holmgren R; Holmgren B; Anias J
    Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.